Strategic Partners

Strategic Partners provide the knowledge, critical skills and expertise to help you overcome hurdles and grow your business. They all offer competitive pricing on their products and services. Some offer discounts. Check this space frequently for the addition of new firms.

Practice Areas Economic Development Litigation Support Public Policy and Finance Planning Real Estate Transportation Technical Applications Economic and Fiscal Impact Analyses Market and Feasibility Studies Geospatial Analyses Benefit-Cost Analyses Pro-Forma Modeling Econometric and Statistical Analyses EB-5 Program Services Government Grant Application Assistance For More Information Stephen P. Mullin mullin@econsultsolutions.com Richard P. Voith voith@econsultsolutions.com Peter A. Angelides angelides@econsultsolutions.com Lee Huang huang@econsultsolutions.com Daniel Miles miles@econsultsolutions.com Steve Wray wray@econsultsolutions.com 1435 Walnut St., 4th Floor, Philadelphia, PA 19102 215-717-2777 \| econsultsolutions.com	Economics, Policy, Strategy Econsult Solutions, Inc. (ESI) provides businesses and public policymakers with economic consulting services in urban economics, real estate economics, transportation, public infrastructure, development, public policy and finance, community and neighborhood development, planning, as well as litigation support. ESI has the capability to engage in projects of any size, from comprehensive long-term studies involving complicated economic arguments and extensive data analysis, to short-term advisory support. Whether working independently or on joint-venture projects, our flexibility and customized approach allow us to respond to a vastrange of client needs. Our scope is large, and our expertise specific. ESI assists clients in the evaluation of economic and fiscal outcomes of programs and developments, offers city and regional planning insight and advice, provides GIS analytic services, yields financial projections and advises investors and governments on projects, developments, and policy outcomes, and has the economic skills and expertise to process, analyze and manage large and complex datasets. Our Principals and Senior Advisors include nationally recognized experts in urban development, real estate, government and public policy, planning, transportation, non-profit management, business strategy and administration, as well as litigation and commercial damages. Staff members have outstanding credentials, including active positions at the university level, wide experience at the highest levels of the public policy process and extensive consulting experience
TechLink assists companies ranging in size from one-person startups to Global 100 corporations. Most have fewer than 100 employees. Through TechLink, companies and startups can access over 5,000 new DoD inventions, greatly leverage their R&D investments, and more successfully develop and commercialize new technologies. TechLink can also facilitate CRADAs for joint-research with the DoD. TechLink Tech Managers assist companies to assess the above technologies and others posted to its searchable database — https://techlinkcenter.org/technologies/ making sure the technology matches the company’s purpose. If the company wants to proceed with licensing, the Tech Manager walks the company through exclusive, non-exclusive or in some cases Express licensing options. Its aim is to assist associations in making their member companies more successful through commercializing innovative technologies (NMBio is the first of BIO’s 48 state affiliates to be selected as a partner). Yvonne Rudman Industry Liaison TechLink Center A 2310 University Way, Bldg 2-2, Bozeman, MT 59717 O (406) 994.7796 E yvonne.rudman@techlinkcenter.org	TechLink TechLink, which creates high-value partnerships between the Department of Defense (DoD) and industry to develop, transfer and transition licensing and technologies. Its focus in medical and biotechnology research/inventions includes preventable and therapeutic vaccine treatments, antibodies, diagnostic tests, wound care products and health related software: https://techlinkcenter.org/technologies-category/medical-biotechnology/ TechLink’s primary activity is marketing new inventions from Department of Defense labs and — at no cost — facilitating license agreements for these inventions, according to Yvonne Rudman, who will serve as NMBio’s primary contact to the organization. TechLink helps companies to: Evaluate DoD inventions Develop high-quality license applications and commercialization plans Partner with DoD labs for joint technology research facilities Gain access to world-class DoD research facilities Compete more effectively for DoD SBIR/STTR funding for new technology development Provides economic impact studies of DoD technology transfer and SBIR agreements Organizes innovation discovery workshops to generate more and better patents from DoD labs TechLink’s “Defense TechLink” program is DoD’s primary national partnership for technology transfer. DoD – the largest research entity in the world — has approximately 120 labs and research facilities nationwide, involving the Air Force, Army, Navy, and specialized agencies such as the National Security Agency. Defense TechLink has facilitated partnerships with most of these centers, linking them with private industry for technology licensing, transfer, and joint R&D.
Contact us today Bob Feinberg Senior Vice President & Principal Albuquerque-Santa Fe-El Paso bob.feinberg@colliers.com 505 238 7707 License #9916 Tom Jones, CCIM Senior Vice President & Principal Albuquerque-Santa Fe-El Paso tom.jones@colliers.com 505 880 7063 License #37218 5051 Journal Center Blvd NE Suite 200 Albuquerque, NM 87109 colliers.com/newmexico	The best choice for all your life and bioscience real estate needs. What sets us apart is not what we do, but how we do it. Our enterprising culture encourages Colliers people to think differently, share great ideas and create effective solutions that help clients accelerate their success. Colliers is the advisor of choice for many of the most innovative and successful companies. A market leader in New Mexico for over 30 years, our team of experts provides every client with excellence in service, solutions and results. Our team features expertise in the full spectrum of transaction services, including office, investment, industrial, retail, land, multifamily properties, property management, business brokerage and valuation services. We provide our clients with a deep level of knowledge in bioscience industries and product types. With our integrated services approach we can assist in aligning your real estate strategy with your core business, resulting in optimized real estate assets and increased productivity. Our Services Landlord Representation Tenant Representation Sales Representation Property Management Corporate Solutions Valuation and Advisory Services Project Management Research Marketing Asset Resolution Build-to-Suit Dispositions and Subleases Facility Relocations and Acquisitions In-Depth Location Analysis Lease and Operating Cost Audits Lease Negotiation and Renewal Space Expansion and Consolidation Supplier/Employee Mapping
Contract Research to Enable your Drug Development or Cell Therapy Program to Succeed Being the first to market with your drug discovery is critical to healthcare outcomes, raising investment dollars, and market-share. Likarda’s services bridge the gaps in your research program or lab so you can move R&D forward confidently and quickly. When you need drug development research support, but time and costs are limited, outsourcing to Likarda makes sense. Likarda is a proud supporter of NMBio (New Mexico Biotechnology and Biomedical Association). Current members of NMBio receive a minimum 5% discount on research services. Karthik Ramachandran, Ph.D. \| Vice President & Co-Founder Likarda, LLC \| www.likarda.com 10330 Hickman Mills Drive, Suite B, Kansas City, MO 64137 karthik@likarda.com \| office 816.605.6440 ext.103 \| cell 303.981.5862 Support Well beyond Providing Data But data is just data. We know there is far more to working with science entrepreneurs in the early discovery phase—such as passion and drive. Likarda’s team invests our expertise in you, taking time to understand your ultimate goals and customizing the research to meet them. Our only stake is in helping you succeed, not in ownership of your intellectual property. Likarda performs human and veterinary drug discovery and development services in these areas: Pharmaceutical Nutraceutical Supplements Herbal products Cosmetics and hygiene Other health care products When your success hinges on quality data and researchers who have a deep understanding of the data’s implications and can provide ongoing support, that’s Likarda.	Likarda Outsourcing CRO Work Offers Drug Discovery Research at Entrepreneurial Speed Entrepreneurs and small pharmaceutical companies face demands and challenges from numerous directions. Data is needed to obtain financial support, submit strong patent applications, or strengthen a market strategy. Often the projects must be subdivided into smaller portions due to limited funding or access to the product. Adept in projects big or small Likarda is a world-class, cutting-edge biotech research laboratory for science entrepreneurs. When you outsource CRO work to Likarda, we combine comprehensive research and development with consultative and analytical services so that you can move ahead in the drug development process with confidence, efficiency, and success at an affordable rate. One Week in Our Time Is One Month in Traditional Lab TimeOutsourcing your CRO projects to Likarda, means you can bring products to market in a fraction of the time based on data we collect using a wide range of the same early-phase tests of large contract research organizations (CROs) such as: Toxicology Metabolism Cell health assays Pharmacodynamics studies Other cell-based assays Pre-clinical animal studies Biological and Cell-based Assay ServicesWe test different drugs with known effects in humans using the conventional pharmaceutical approach and our proprietary 3D cell cluster for better predictability of drug interaction in humans. Our micromold forms and tests 200,000 clusters compared to 384 cell clusters in a normal cell culture plate. 3D models are developed in cancer, diabetes, stem cells, liver and other areas, leading to endpoints like viability, toxicity, metabolism, protein production, proliferation, penetration, diffusion, mechanism of death, mechanism of action, and more depending on your goals. Analytical ServicesWe provide several analytical services to further analyze your product or compounds including HPLC, mass spectrometry, method development, assay validation, environmental/photostability storage and testing, and spent media analysis (amino acid analysis). Drug Discovery and ScreeningWe are dedicated specialists who listen to your needs and build a customized solution. Our experts in screening, profiling, and custom assay development, supplement your research team with support before, during, and after your testing. Our robotic and automated approach to high-throughput 3D compound screening and optimization helps you in early efficacy and toxicity screening, formulation optimization, and enables you to quickly get the data you need to make the most informed decisions about your drug development pathway or product pipelines.
MEDFAS founder Sam Macrina, after 44+ years of commercial banking experience, saw a need for national exposure to a U S Treasury economic development incentive which subsidizes the interest expense of a company’s expansion project. Under this program, the U S Treasury will pay up to $2.4 million of a company’s interest expense. MEDFAS (Manufacturers Economic Development Financing Associates) was formed in 2013 to help Economic Development Professional and Bankers work together to create Jobs and increase economic development within their communities. Helping Manufacturers successfully access billions of dollars in Tax Advantage Financing, resulting in an average savings of 31% in interest expense alone. Offering personal and online training opportunities to help companies and economic development professionals understand and apply for Tax Advantage Financing. Sam Macrina SVP, MSRB registered Manufacturing Economic Development Financing Assoc. 610 763 2310 smacrina@medfas.com www.linkedin.com/in/sammacrina www.Medfas.com Helping foreign and domestic manufacturers expand and invest: Low-cost capital access remains the primary strength of tax-exempt financing. Across the United States there are billions of dollars available every year for manufacturers to use to fund new projects and expansion plans.	MEDFAS Tax-Exempt Financing is a federally-authorized development finance tool that helps stimulate public and private investment including Foreign Direct Investment in the United States. Tax-exempt financing is a broad term that also includes tax-exempt loans made by a bank or private lender to a private enterprise to finance the costs of capital projects. Tax-exempt financing is used for the purpose of investing in new facilities, production lines, machinery and equipment, and technological advancements that help bolster productivity and profit. Tax-Exempt Financing may be used to fund the following assets: Land: Includes acquisition, site preparation and improvements, infrastructure development (e.g., water, sewer & rail) and environmental testing. Building: Includes acquisition, construction, rehabilitation, engineering, architectural, legal and other related costs. Soft Costs: Includes legal, architectural, engineering, surveying, test boring, title insurance, appraisals, accounting and financing costs for the project. Equipment: Includes acquisition, delivery and installation. Company Acquisition: The acquisition of a manufacturing company structured as an asset purchase can be financed with tax-exempt debt.

Trust our MedTech market expertise. Let us guide you through the complicated maze of rules and regulations – always ensuring safety, efficacy and ease of use for the physician or clinician. The Yar Group’s significant medical device development and go to-market experience helps our clients create strategies to ensure compliance, and prepare for key FDA, CE mark, Australian TGA and other regulatory agency applications. With our guidance, you can:

Speed your time to market
Meet or surpass regulations both domestic and abroad

• Create a quality-driven approach to design, manufacturing, testing, and launch

Understand marketing and labeling requirements

Identify market issues with user-evaluation studies

• Determine optimal domestic and international distribution models

Contact Us

Rick Thomson Managing Partner Off 505.805.5002 Cell 972.407.1988

rick.thomson@theyargroup.com https://theyargroup.com/

Need an assist with Medical Devices? Involvement with unique and innovative technology that dramatically improves outcomes is where we thrive. When you want to move as agilely and effectively as possible, we share your drive for urgency. We do this through providing fractional leadership in key executive positions for any stage of business. We know what questions to ask at the concept phase that will impact quality systems, design efforts, testing, regulatory clearances, and auditing and marketing requirements much further down the road. We know because we have taken new technology concepts from design to prototype to completed product. And guided companies through the high-stakes maze of medical device development and clearances. We’ve navigated the often conflicting market, regulatory, and user requests that inform medical device development from the start.

Point A Consulting is a strategic planning practice that focuses on technology-based economic development initiatives designed to strengthen and promote the knowledge economy assets of client communities. Spalding’s forte is integrating assessment of market opportunities with physical development strategies, to achieve place-based solutions as catalysts for growing regional innovation eco-systems. His 30 years of experience includes leadership roles with research parks and technology incubators, as well as community-wide strategic planning initiatives. Since founding Point A Consulting in 2007, he has undertaken engagements related to strategic plans for innovation and technology-based economic development across the country, in partnership with leading urban design, technology commercialization and strategy consultancies. Point A Consulting member of the Association of University Research Parks (AURP)

Practice Focus Strategy & implementation for technology-based economic development for: • Research Parks • Incubators / Accelerators • Innovation “Eco-systems” / Cluster Development Clients Universities, Regional Partnerships, Economic Development Organizations, Developers, Local & State Governments

For more information: email Steven Spalding

or call 502-744-8115

Point A Consulting

Projects Include:

Research park and incubator advisory services include: Strategy & Positioning Cluster Development International Linkages Market & Technology Assessment Best Practices in Governance, Marketing, Staffing, Financing, etc. Stakeholder Engagement / Community Relations Marketing and Communications Strategies Implementation [Business] Plans Interim Operations / Management Real Estate Development / Public Private Partnership

AWS Bio-Pharma Technologies provides the highest quality, cost-effective solutions for the pharmaceutical and related manufacturing industries. In addition, we possess strategic partnerships with other manufacturers of pharmaceutical equipment allowing us to provide quality, flexibility and value for a truly integrated solution. We focus on supporting our clients from the initial discussion, throughout installation, and through our continuous support long after the project has been completed. Bruce Anthenat CEO AWS Bio-Pharms Technologies (505) 286-3944 (505) 259-8903 (m) Bruce@AWSBioPharma.com

AWS Bio-Pharma Technologies

We bring you effective processing solutions

ASEPTIC FILL-FINISH SYSTEMS

Our Aseptic Fill Finish Systems include Traditional Filling Lines, Isolated Filling Lines, Nested Filling Lines, Robotic Filling Lines and IV Bag Filling Lines. FULL FEATURES

ASEPTIC SUPPORT PROCESSING

Our Aseptic Support Processing Systems include Inspection/Leak-Testing Systems, IV Bag Processing Systems, SBM Processing Systems, FFS Processing Systems and Containment Systems. FULL FEATURES

COMPOUNDING-FORMULATION

Our Pharmaceutical Compounding Equipment includes CIP-SIP Systems, Mixing Systems, Robotic Systems, Tankage, Containment Systems and 503B Compounding Facilities. FULL FEATURES

PHARMACEUTICAL FACILITIES

Our Pharmaceutical Facilities include Modular Cleanroom Systems, Water Purification Systems, Decontamination Facility Systems (Biowaste, Washing) and Turn-key Systems. FULL FEATURES

We turn non-dilutive funding into a strategic source of funding for life science organizations

EXPERIENCE

Established in 1999, FreeMind is the largest consulting group of its kind working with academics and Industry alike. We assist in maximizing potential to receive funding from non-dilutive sources such as the NIH, DOD, NSF, FDA, BARDA, etc., as well as Private Foundations.

EXPERTISE

FreeMind’s knowledgeable and experienced team of Client Strategists and Project Managers are dedicated to guiding non-dilutive funding efforts from identification of the most suitable opportunity through to submission and subsequent award.

SUCCESS

FreeMind’s proven long-term strategic approach has garnered its clients over 1.5 billion dollars to date. Awards range from $150,000 to $150,000,000 per project. Our team of experts will assist in making non-dilutive funding a key tool in a long-term sound financial strategy.

FreeMind

Ayal Ronen, VP The FreeMind Group 423 Brookline Ave., #124 Boston, MA 02215 617-648-0340 | 908 502 2925 (m)

Creative Strategies for Economic Development Organizations & Assets Sean O’Shea, MBA Founder & President HatchForm 3900 Paseo del Sol Santa Fe, NM 87507 505-699-4229 | sean@hatchform.com

HatchForm

HatchForm creates programs and strategies for economic development organizations and assets. 1. Business Incubators & Accelerators HatchForm assists Business Incubators, Accelerators and other entrepreneur focused economic development assets like Innovation Hubs, Maker Spaces, Tech Transfer Offices etc. create or update their client centric strategies and organizational value propositions. HatchForm also leads strategic forums, conducts market and community supply analysis, and completes feasibility studies for future Business Incubators or other proposed assets 2. Economic Development Organizations HatchForm helps EDO’s refine their strategic approach to community wealth creation through targeted, impactful, and sustainable tactical programming. EDO assistance includes creating programs like BR&E, Cluster Analysis and Implementation, EcoSystem and Asset Mapping, etc. HatchForm also uses it’s own approach based on the Three Horizon Framework to create strategies around base, emerging, and embryonic industries within each community. HatchForm believes that focused, innovative and metric driven programs are a cornerstone of any organization’s strategic implementation. 3. Communities Using methods pioneered at the Agile Strategy Lab incorporated with our own tools like the Economic Development Strategy Canvas, HatchForm helps communities create strategies that can be immediately implemented and won’t just collect dust on the city manger’s shelf.

Strategic Partners